Sana Biotechnology, Inc.SANANASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank57
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-4.22
↑ 94% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-73.52
Historical baseline
PeriodValueYoY Change
2025-4.22-199.2%
2024-1.41+49.7%
2023-2.80-1.5%
2022-2.76+61.9%
2021-7.24+68.6%
2020-23.07+54.1%
2019-50.28+89.9%
2018-496.39-